Photo of Geoffrey Kline

View Scopus Profile

Geoffrey Kline, DO, PhD

  • 9 Citations
  • 1 h-Index
1996 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Projects

Filter
Active
Active

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).

Kline, G.

Boehringer Ingelheim International GmbH

25/04/17 → 24/04/21

Project: Research

A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

Kline, G.

Boehringer Ingelheim International GmbH

25/04/17 → 24/04/21

Project: Research

PROMINENT- PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES

Kline, G.

Kowa Research Institute, Inc.

31/03/17 → 31/03/21

Project: Research

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (ETC-I 002) on the Occurrence of Major Cardiovascular Events in Patients with, or at High Risk For,Cardiovascular Disease Who Are Statin Intolerant

Kline, G.

Esperion Therapeutics, Inc.

13/02/17 → 13/02/21

Project: Research

A Long-term Outcomes Study to Assess Statin Residual Risk Reduction with EpaNova High Cardiovascular Risk Patients witgh Hypertriglyceridemia (STRENGTH)

Kline, G.

Astra Zeneca

8/06/15 → 30/06/24

Project: Research